Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome
by University of Texas MD Anderson Cancer Center edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Immunogenic FSPs are present in cancer and precancer lesions of LS carriers from an independent cohort. Credit: Nature Medicine (2026). DOI: 10.1038/s41591-025-04182-9 The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to […]
